silver has been researched along with Cockayne-Touraine Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Browning, JC; Levy, ML | 1 |
1 other study(ies) available for silver and Cockayne-Touraine Disease
| Article | Year |
|---|---|
Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa.
Topics: Administration, Cutaneous; Adult; Anti-Infective Agents, Local; Argyria; Epidermolysis Bullosa Dystrophica; Female; Humans; Male; Middle Aged; Risk Factors; Silver; Silver Sulfadiazine; Skin; Skin Absorption | 2008 |